NPRL2 Gene

📖 Wiki Page

gene2362 wordssynced 2026-04-02

NPRL2 Gene

Introduction

...

NPRL2 Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NPRL2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>NPRL2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NPR2-Like (GATOR1 Complex Subunit)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>3p21.31</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10316</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000131653</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8WX92</td>
</tr>
<tr>
<td class="label">Component</td>
<td>Function</td>
</tr>
<tr>
<td class="label">GATOR1</td>
<td>Rag GAP activity</td>
</tr>
<tr>
<td class="label">GATOR2</td>
<td>Positive regulator</td>
</tr>
<tr>
<td class="label">Sestrin1/2</td>
<td>Leucine sensing</td>
</tr>
<tr>
<td class="label">CASTOR1/2</td>
<td>Arginine sensing</td>
</tr>
<tr>
<td class="label">SAMTOR</td>
<td>Methionine sensing</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">DEPDC5</td>
<td>GATOR1 subunit</td>
</tr>
<tr>
<td class="label">TSC1/2</td>
<td>Parallel mTOR regulation</td>
</tr>
<tr>
<td class="label">FLCN</td>
<td>mTOR regulation</td>
</tr>
<tr>
<td class="label">PTEN</td>
<td>PI3K-mTOR pathway</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Sirolimus (Rapamycin)</td>
<td>Allosteric mTORC1 inhibitor</td>
</tr>
<tr>
<td class="label">Everolimus</td>
<td>Rapamycin analog</td>
</tr>
<tr>
<td class="label">Torin1</td>
<td>Catalytic mTOR inhibitor</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Function</td>
</tr>
<tr>
<td class="label">NPRL2</td>
<td>Catalytic GAP activity</td>
</tr>
<tr>
<td class="label">NPRL3</td>
<td>Structural scaffold</td>
</tr>
<tr>
<td class="label">DEPDC5</td>
<td>Regulatory subunit</td>
</tr>
<tr>
<td class="label">Autophagy Stage</td>
<td>NPRL2 Effect</td>
</tr>
<tr>
<td class="label">Initiation</td>
<td>ULK1 complex activation</td>
</tr>
<tr>
<td class="label">Nucleation</td>
<td>PI3K-III complex recruitment</td>
</tr>
<tr>
<td class="label">Elongation</td>
<td>LC3 lipidation</td>
</tr>
<tr>
<td class="label">Fusion</td>
<td>Autophagosome-lysosome fusion</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>NPRL2 Expression</td>
</tr>
<tr>
<td class="label">Pyramidal neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Interneurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Seizure type</td>
<td>Focal seizures, often with auditory features</td>
</tr>
<tr>
<td class="label">Onset</td>
<td>Childhood to adolescence</td>
</tr>
<tr>
<td class="label">Penetrance</td>
<td>Incomplete (60-70%)</td>
</tr>
<tr>
<td class="label">EEG findings</td>
<td>Temporal/focal epileptiform discharges</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Rapamycin</td>
<td>mTORC1</td>
</tr>
<tr>
<td class="label">Everolimus</td>
<td>mTORC1</td>
</tr>
<tr>
<td class="label">Torin1</td>
<td>mTORC1/mTORC2</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">AMPK</td>
<td>Energy sensing</td>
</tr>
<tr>
<td class="label">ULK1</td>
<td>Autophagy initiation</td>
</tr>
<tr>
<td class="label">TFEB</td>
<td>Lysosomal biogenesis</td>
</tr>
<tr>
<td class="label">Wnt</td>
<td>Developmental signaling</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Use</td>
</tr>
<tr>
<td class="label">Yeast</td>
<td>Basic mechanisms</td>
</tr>
<tr>
<td class="label">Drosophila</td>
<td>Development</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>Development, screening</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>In vivo models</td>
</tr>
<tr>
<td class="label">iPSC neurons</td>
<td>Disease modeling</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">mTORC1</td>
<td>Inhibition</td>
</tr>
<tr>
<td class="label">GATOR1</td>
<td>Stabilization</td>
</tr>
<tr>
<td class="label">Autophagy</td>
<td>Induction</td>
</tr>
<tr>
<td class="label">Metabotropic</td>
<td>Ketogenic diet</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">20 edges</a></td>
</tr>
</table>

Nprl2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The NPRL2 gene (NPR2-Like, GATOR1 Complex Subunit) encodes a core component of the GATOR1 complex, which negatively regulates mTORC1 signaling in response to amino acid availability. NPRL2 is a tumor suppressor and mutations cause familial epilepsy. Dysregulated [mTOR](/entities/mtor) signaling is a hallmark of many neurodegenerative diseases. [@gator]

Gene Information

Protein Structure

NPRL2 is a 380-amino acid protein with:

GAP activity towards Rag GTPases
Protein-protein interaction domains
Multiple phosphorylation sites

Molecular Function

NPRL2 is essential for mTORC1 inhibition:

GATOR1 Complex: Forms the catalytic core of the complex

Rag GAP Activity: Inactivates Rag GTPases to inhibit mTORC1

Amino Acid Sensing: Integrates amino acid signals

Tumor Suppression: Prevents cell growth under stress

Expression Pattern

NPRL2 is ubiquitously expressed:

High in brain, heart, kidney
Moderate in liver, lung
Low in other tissues

In the brain:

[Neurons](/entities/neurons) in [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
Cerebellar Purkinje cells
Glial cells

Disease Associations

Focal Epilepsy

Autosomal dominant focal epilepsy (FLE)
Mutations cause epilepsy without brain lesions
Incomplete penetrance
PMID: 23471845(https://pubmed.ncbi.nlm.nih.gov/23471845/), PMID: 23695510(https://pubmed.ncbi.nlm.nih.gov/23695510/)

Alzheimer's Disease

mTORC1 hyperactivation in AD
Impaired autophagy leads to protein aggregation
Synaptic plasticity deficits
PMID: 25396082(https://pubmed.ncbi.nlm.nih.gov/25396082/), PMID: 26255403(https://pubmed.ncbi.nlm.nih.gov/26255403/)

Parkinson's Disease

Dysregulated [mTOR](/mechanisms/mtor-signaling-pathway) signaling
[Autophagy](/entities/autophagy) defects in PD
[Alpha-synuclein](/proteins/alpha-synuclein) accumulation
PMID: 26925799(https://pubmed.ncbi.nlm.nih.gov/26925799/), PMID: 28749530(https://pubmed.ncbi.nlm.nih.gov/28749530/)

Tuberous Sclerosis

Related to TSC1/TSC2 pathway
mTOR hyperactivation
Seizures and developmental issues

Cancer

Tumor suppressor
Loss in various cancers
Renal cell carcinoma

Therapeutic Implications

mTOR Inhibitors: Rapamycin, everolimus
Autophagy Inducers: Trehalose, resveratrol
Ketogenic Diet: Bypasses mTOR dysregulation
Gene Therapy: For epilepsy

Animal Models

Nprl2 knockout mice: Embryonic lethal
Conditional knockouts: Seizures, autism-like behaviors
Zebrafish: Developmental defects

Background

The study of Nprl2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[NCBI Gene NPRL2](https://www.ncbi.nlm.nih.gov/gene/10316)
[UniProt Q8WX92](https://www.uniprot.org/uniprotkb/Q8WX92)
[HGNC NPRL2](https://www.genenames.org/data/hgnc_data.php?hgnc_id=8004)
[Ensembl NPRL2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000131653)

Molecular Mechanisms

GATOR1 Complex Assembly and Function

The GATOR1 complex represents the primary amino acid sensing machinery that negatively regulates mTORC1 signaling[gator]. NPRL2 serves as the central scaffold that coordinates complex assembly:

NPRL2 dimerization: Forms homodimers that provide the structural foundation

NPRL3 recruitment: NPRL3 binds to NPRL2 dimers through coiled-coil interactions

DEPDC5 association: The largest subunit (1603 aa) associates as the catalytic component

Complex activation: Amino acid starvation triggers GATOR1 activation

The complete complex has a molecular weight of approximately 350 kDa and localizes primarily to the cytosol, with enrichment at the lysosomal surface where mTORC1 activation occurs.

Rag GTPase Regulation

NPRL2 directly catalyzes GTP hydrolysis on Rag GTPases, a critical regulatory step:

Rag GTPase structure: Heterodimers of RagA/B (or Rag1/2) with RagC/D (or Rag3/4)
Active state: RagA/B-GTP recruits mTORC1 to the lysosomal surface
Inactive state: GDP-bound Rags prevent mTORC1 recruitment
NPRL2 GAP activity: Accelerates GTP hydrolysis on RagA/B by ~10,000-fold
Substrate specificity: Prefers RagA over RagB; exhibits some specificity for RagC

Amino Acid Sensing Pathway

The GATOR1 complex functions within a larger amino acid sensing network:

Integration with Cellular Metabolic Status

NPRL2 function intersects with multiple metabolic pathways:

AMPK signaling: Energy depletion activates AMPK, which phosphorylates and inhibits mTORC1 through TSC1/2
Growth factor signaling: PI3K-Akt pathway modulates mTORC1 activity independently of amino acids
Stress responses: p53 and hypoxia-inducible factor pathways affect GATOR1 function

Neurological Disease Mechanisms

Alzheimer's Disease Pathogenesis

In Alzheimer's disease, NPRL2 dysfunction contributes to several key pathological features:

mTORC1 hyperactivation: Reduced GATOR1 activity permits uncontrolled mTORC1 signaling
Autophagy impairment: Active mTORC1 inhibits autophagy initiation, blocking clearance of Aβ and tau
Synaptic dysfunction: mTOR-regulated local protein synthesis at synapses becomes dysregulated
Protein synthesis dysregulation: Aberrant phosphorylation of 4E-BP and S6K affects synaptic plasticity

Parkinson's Disease Mechanisms

NPRL2 alterations in PD involve:

mTOR pathway dysregulation: Altered mTOR signaling in dopaminergic neurons
Autophagy defects: Impaired autophagic clearance of alpha-synuclein aggregates
Lysosomal dysfunction: Connection to GBA and other lysosomal genes mutated in PD
Neuronal vulnerability: Enhanced susceptibility of substantia nigra neurons

Epilepsy Pathophysiology

NPRL2 mutations cause focal epilepsy through[nprl]:

GATOR1 dysfunction: Loss of mTORC1 inhibition

mTORC1 hyperactivation: Increased protein synthesis at synapses

Neuronal hyperexcitability: Altered ion channel expression and function

Network hypersynchrony: Excessive neuronal connectivity leading to seizures

Interaction with Other Neurodegeneration Genes

NPRL2 interacts with multiple genes implicated in neurodegeneration:

Therapeutic Strategies

mTOR Inhibitors in Clinical Practice

Autophagy-Inducing Strategies

Beyond mTOR inhibition, alternative autophagy enhancement approaches:

Trehalose: mTOR-independent autophagy inducer
Resveratrol: SIRT1-dependent autophagy activation
Lithium: IMPase inhibition, inositol depletion
Carbamazepine: TFEB activation

Gene Therapy Approaches

For NPRL2-related epilepsy:

AAV-mediated delivery: Brain-targeted vector systems
CRISPR-based correction: Allele-specific editing
Antisense oligonucleotides: Variant-specific targeting

Ketogenic Diet Therapy

Metabolic therapy offers an alternative approach:

Mechanism: Reduces glycolysis, increases ketone utilization
Effect on mTOR: Decreases mTORC1 signaling through AMPK activation
Benefits: Seizure reduction, improved cognition
Considerations: Dietary compliance, lipid profile

Research Models and Methods

Cellular Models

Neuronal cultures: Primary cortical and hippocampal neurons
iPSC-derived neurons: Patient-specific disease modeling
Organotypic slices: Preserved brain architecture

Animal Models

Nprl2 knockout mice: Embryonic lethal (E7.5-9.5)
Conditional knockouts: Brain-specific deletion for survival
heterozygous mice: Show behavioral abnormalities

Experimental Approaches

CRISPR/Cas9: Gene editing for mutation modeling
Proteomics: GATOR1 complex composition analysis
Metabolomics: Metabolic pathway profiling
Single-cell RNAseq: Cell type-specific expression

Biomarkers and Diagnostics

Genetic Testing

Panel testing: Epilepsy gene panels including NPRL2
Whole exome sequencing: Comprehensive variant detection
Family screening: Cascade testing for relatives

Functional Assays

Fibroblast studies: mTORC1 hyperactivation assessment
Protein expression: Western blot for NPRL2 levels
Enzyme activity: Rag GAP activity measurement

Summary

NPRL2 (NPR2-Like, GATOR1 Complex Subunit) encodes a core component of the GATOR1 complex, the primary negative regulator of mTORC1 signaling in response to amino acid availability. Through its catalytic GAP activity toward Rag GTPases, NPRL2 plays essential roles in nutrient sensing, autophagy regulation, protein synthesis control, and cellular growth decisions. Mutations in NPRL2 cause autosomal dominant focal epilepsy, while dysregulated mTORC1 signaling contributes to Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Understanding NPRL2 function provides insights into the pathogenesis of these conditions and identifies therapeutic targets for intervention.

Brain Atlas Resources

Allen Human Brain Atlas: [Gene expression search](https://human.brain-map.org/microarray/search/show?search_term=NPRL2)
Allen Mouse Brain Atlas: [Gene search](https://mouse.brain-map.org/search/index.html?query=NPRL2)
Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
BrainSpan Developmental Transcriptome: [Developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=NPRL2)

References

[Unknown, - NPRL2 mutations cause epilepsy (n.d.)](https://pubmed.ncbi.nlm.nih.gov/23471845/)

[Unknown, - GATOR1 complex structure (n.d.)](https://pubmed.ncbi.nlm.nih.gov/23695510/)

[Unknown, - mTOR in AD (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25396082/)

[Unknown, - Autophagy mechanisms (n.d.)](https://pubmed.ncbi.nlm.nih.gov/26255403/)

[Unknown, - PD mechanisms (n.d.)](https://pubmed.ncbi.nlm.nih.gov/26925799/)

[Unknown, - mTOR signaling (n.d.)](https://pubmed.ncbi.nlm.nih.gov/28749530/)

GATOR1 Complex Architecture

Structure and Composition

The GATOR1 complex is a multi-subunit complex that functions as the primary negative regulator of mTORC1 signaling in response to amino acid starvation. NPRL2 forms the catalytic core of this complex[@gator]:

Mermaid diagram (expand to render)

Each component plays distinct roles:

Rag GTPase Regulation

NPRL2 functions as a GTPase-activating protein (GAP) for Rag GTPases[@gator]:

RagA/RagB: Rag heterodimers sense amino acid availability
GTP hydrolysis: NPRL2 promotes Rag inactivation
mTORC1 recruitment: Inactive Rag prevents mTORC1 lysosomal localization
Amino acid sensing: Links nutrient status to growth signaling

Molecular Mechanisms

mTORC1 Signaling Pathway

The mTOR (mechanistic target of rapamycin) pathway is a central regulator of cell growth and metabolism[@mtor]:

Nutrient sensing: GATOR1 monitors amino acid levels

mTORC1 activation: Growth signals promote protein synthesis

Autophagy inhibition: Active mTORC1 suppresses autophagy

Translation regulation: Controls ribosome biogenesis and mRNA translation

Autophagy Regulation

NPRL2 indirectly regulates autophagy through mTORC1 inhibition[@autophagy]:

When NPRL2 is functional, mTORC1 remains inhibited, permitting autophagy to proceed. Loss of NPRL2 function leads to mTORC1 hyperactivation and autophagy blockade.

Brain-Specific Functions

Neuronal mTOR Regulation

In neurons, NPRL2-mediated mTOR regulation has unique features[@mechanisms]:

Synaptic plasticity: mTOR controls local protein synthesis at synapses
Neuronal morphology: Regulates dendritic arborization and spine formation
Activity-dependent translation: Links neural activity to protein synthesis
Circuit refinement: mTOR dysregulation affects circuit development

Cell Type-Specific Expression

Epilepsy Mechanisms

Focal Epilepsy

NPRL2 mutations cause autosomal dominant focal epilepsy[@nprl]:

The mechanism involves:

GATOR1 dysfunction: Loss of mTORC1 inhibition

mTORC1 hyperactivation: Increased protein synthesis

Neuronal hyper excitability: Altered synaptic plasticity

Seizure generation: Network hyperexcitability

mTORopathies

NPRL2-related epilepsy is part of a broader group of "mTORopathies":

Focal cortical dysplasia
Tuberous sclerosis
Hemimegalencephaly
DEPDC5-related epilepsy

These disorders share mechanistic features and may respond to mTOR inhibitors.

Therapeutic Approaches

mTOR Inhibitors

Clinical considerations:

Efficacy: Significant seizure reduction in many patients
Adverse effects: Immunosuppression, metabolic effects
Treatment duration: Often lifelong
Combination therapy: May enable dose reduction

Autophagy Induction

Alternative approaches target autophagy directly[@autophagy]:

Trehalose: mTOR-independent autophagy inducer
Resveratrol: SIRT1-dependent autophagy
Lithium: Autophagy through IMPase inhibition
Carbamazepine: Autophagy enhancement

Structural Biology

Protein Domain Architecture

NPRL2 contains several functional domains:

NPRL2-specific domain: Conserved region unique to NPRL2 proteins

Coiled-coil domains: Mediate protein-protein interactions

Rag interaction interface: Binds Rag GTPases

DEPDC5 binding site: Interfaces with GATOR1 complex

Structural Studies

Cryo-EM studies have elucidated:

GATOR1 complex architecture
NPRL2-NPRL3 interaction
Rag GTPase binding conformation

Signaling Networks

Amino Acid Sensing Pathway

Mermaid diagram (expand to render)

Integration with Other Pathways

NPRL2 intersects with multiple signaling networks:

Clinical Implications

Diagnosis

Genetic testing for NPRL2 variants:

Sequencing: Panel or whole exome
Interpretation: Pathogenic vs. VUS
Family testing: Cascade screening

Prenatal Testing

Available for:

Known familial variants
Preimplantation testing
Carrier testing

Research Tools

Model Systems

Experimental Techniques

CRISPR/Cas9 editing
Proteomics
Metabolomics
Single-cell RNAseq

Therapeutic Development

Drug Targets

Clinical Trial Design

Considerations for NPRL2-related epilepsy:

Genotype-phenotype correlation
Seizure frequency endpoints
Quality of life measures
Long-term outcomes

Biomarkers

Therapeutic Response Markers

Seizure frequency
EEG normalization
Cognitive function
Brain imaging

Disease Progression

Developmental milestones
Neurological exam
Biomarker levels

Pathway Diagram

The following diagram shows the key molecular relationships involving NPRL2 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

NPRL2 Gene

NPRL2 Gene

Introduction

NPRL2 Gene

Introduction

Overview

Gene Information

Protein Structure

Molecular Function

Expression Pattern

Disease Associations

Focal Epilepsy

Alzheimer's Disease

Parkinson's Disease

Tuberous Sclerosis

Cancer

Therapeutic Implications

Animal Models

Background

See Also

External Links

Molecular Mechanisms

GATOR1 Complex Assembly and Function

Rag GTPase Regulation

Amino Acid Sensing Pathway

Integration with Cellular Metabolic Status

Neurological Disease Mechanisms

Alzheimer's Disease Pathogenesis

Parkinson's Disease Mechanisms

Epilepsy Pathophysiology

Interaction with Other Neurodegeneration Genes

Therapeutic Strategies

mTOR Inhibitors in Clinical Practice

Autophagy-Inducing Strategies

Gene Therapy Approaches

Ketogenic Diet Therapy

Research Models and Methods

Cellular Models

Animal Models

Experimental Approaches

Biomarkers and Diagnostics

Genetic Testing

Functional Assays

Summary

Brain Atlas Resources

References

GATOR1 Complex Architecture

Structure and Composition

Rag GTPase Regulation

Molecular Mechanisms

mTORC1 Signaling Pathway

Autophagy Regulation

Brain-Specific Functions

Neuronal mTOR Regulation

Cell Type-Specific Expression

Epilepsy Mechanisms

Focal Epilepsy

mTORopathies

Therapeutic Approaches

mTOR Inhibitors

Autophagy Induction

Structural Biology

Protein Domain Architecture

Structural Studies

Signaling Networks

Amino Acid Sensing Pathway

Integration with Other Pathways

Clinical Implications

Diagnosis

Prenatal Testing

Research Tools

Model Systems

Experimental Techniques

Therapeutic Development

Drug Targets

Clinical Trial Design

Biomarkers

Therapeutic Response Markers

Disease Progression

See Also